Kausik Datta

Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.

Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India.

Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.

Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.

Towards a vaccine for Cryptococcus neoformans: principles and caveats.

Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.

Cryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche.

Spread of Cryptococcus gattii into Pacific Northwest region of the United States.

Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans.

The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.

Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency?

Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation.

Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.

Niche-specific requirement for hyphal wall protein 1 in virulence of Candida albicans.